Clinical trials

High Sensitivity Near Patient Cardiac Troponin

Nasal Biomarker for Lung Cancer Screening

A Phase 2 Multi-Cohort, Open-Label, Multi-Center Clinical Study Evaluating the Efficacy and Safety of Disitamab Vedotin (RC48-ADC) Alone and in Combination with Pembrolizumab in Subjects with Locally-Advanced Unresectable or Metastatic Urothelial Carcinoma That Expresses HER2 (Seagen RC48G001)

Reinvent CRT

A Phase III Trial of Lomustine-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients with Methylated MGMT Promoter Glioblastoma (NRG-BN011)

Open-label study of Androgen Receptor Inhibition with Darolutamide plus Androgen Deprivation Therapy (ADT) Versus ADT in men with Metastatic Hormone-Sensitive Prostate Cancer Using an External Control Arm (Bayer 21516 ARASEC)

S1914 - A Randomized Phase III Trial Of Induction/Consolidation Atezolizumab + Sbrt Versus Sbrt Alone In High Risk, Early Stage NSCLC

ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study (Chimerix ACTION)

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery (ASPIRE)

Comparison of Anti-coagulation and Anti-platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA)